<i>Candida albicans</i> Strains Adapted to Caspofungin Due to Aneuploidy Become Highly Tolerant under Continued Drug Pressure

<i>Candida albicans</i> Strains Adapted to Caspofungin Due to Aneuploidy Become Highly Tolerant under Continued Drug Pressure

<i>Candida albicans</i> is a prevalent fungal pathogen of humans. Understanding the development of decreased susceptibility to ECN drugs of this microbe is of substantial interest, as it is viewed as an intermediate step allowing the formation of <i>FKS1</i> resistance mutati...

Full description

Bibliographic Details
Main Authors:	Farha Husain, Anshuman Yadav, Sudisht K. Sah, Jeffrey J. Hayes, Elena Rustchenko
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Microorganisms
Subjects:	<i>Candida albicans</i> caspofungin echinocandins cross-adaptation evolution of drug tolerance aneuploidy
Online Access:	https://www.mdpi.com/2076-2607/11/1/23

Similar Items

<i>Candida albicans</i> Genes Modulating Echinocandin Susceptibility of Caspofungin-Adapted Mutants Are Constitutively Expressed in Clinical Isolates with Intermediate or Full Resistance to Echinocandins
by: Anshuman Yadav, et al.
Published: (2024-03-01)

Genome-Wide DNA Changes Acquired by <i>Candida albicans</i> Caspofungin-Adapted Mutants
by: Jeffrey Zuber, et al.
Published: (2023-07-01)

Susceptibility to caspofungin is regulated by temperature and is dependent on calcineurin in Candida albicans
by: Lijun Zheng, et al.
Published: (2023-12-01)

Identification of 10 genes on Candida albicans chromosome 5 that control surface exposure of the immunogenic cell wall epitope β-glucan and cell wall remodeling in caspofungin-adapted mutants
by: Sudisht K. Sah, et al.
Published: (2023-12-01)

Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
by: Gerardo Becerra Victorio, et al.

Caspofungin-induced β(1,3)-glucan exposure in Candida albicans is driven by increased chitin levels
by: Andrew S. Wagner, et al.
Published: (2023-08-01)

The Effects of Holothurin and Caspofungin on the Vaginal Cell Inflammation Parameters of the Rattus norvegicus Strain Post Induction of Candida albicans
by: Handayani S, et al.
Published: (2023-04-01)

Evaluation of a Novel <i>FKS1</i> R1354H Mutation Associated with Caspofungin Resistance in <i>Candida auris</i> Using the CRISPR-Cas9 System
by: Maiko Kiyohara, et al.
Published: (2023-04-01)

Aneuploidy enables cross-tolerance to unrelated antifungal drugs in Candida parapsilosis
by: Liu-liu Sun, et al.
Published: (2023-04-01)

Antifungal Susceptibility of Oral <i>Candida</i> Isolates from Mother-Infant Dyads to Nystatin, Fluconazole, and Caspofungin
by: Naemah Alkhars, et al.
Published: (2023-05-01)

Resistance to Echinocandins Complicates a Case of <i>Candida albicans</i> Bloodstream Infection: A Case Report
by: Laura Trovato, et al.
Published: (2021-05-01)

Helium Cold Atmospheric Plasma Causes Morphological and Biochemical Alterations in <i>Candida albicans</i> Cells
by: Sabrina de Moura Rovetta-Nogueira, et al.
Published: (2023-12-01)

Caspofungin in Recurrent Fluconazole Resistant Candida Esophagitis Treatment
by: Çiğdem EROL, et al.
Published: (2007-09-01)

Susceptibility of the <i>Candida haemulonii</i> Complex to Echinocandins: Focus on Both Planktonic and Biofilm Life Styles and a Literature Review
by: Lívia S. Ramos, et al.
Published: (2020-10-01)

The efficacy of gaseous ozone against different forms of Candida albicans
by: Mahdis Zargaran, et al.
Published: (2017-06-01)

Necrotizing pancreatitis with invasive candidiasis and candidemia due to Candida albicans and pan-echinocandin-resistant Candida glabrata
by: Laman Rahimli, et al.
Published: (2024-03-01)

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
by: Gebremedhin Beedemariam Gebretekle, et al.
Published: (2022-10-01)

Antifungal Activity of <i>Lavandula angustifolia</i> Essential Oil against <i>Candida albicans</i>: Time-Kill Study on Pediatric Sputum Isolates
by: Stefan Mijatovic, et al.
Published: (2022-09-01)

Peripheral Candidal Suppurative Thrombophlebitis Successfully Treated with Caspofungin in a Bariatric Surgery Patient
by: Özgür GÜNAL, et al.
Published: (2012-12-01)

In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against <i>Candida auris</i>
by: Unai Caballero, et al.
Published: (2021-08-01)

Do <i>Candida albicans</i> Isolates with Borderline Resistant Micafungin MICs Always Harbor <i>FKS1</i> Hot Spot Mutations?
by: Kathrin Spettel, et al.
Published: (2021-01-01)

Cdc14 phosphatase contributes to cell wall integrity and pathogenesis in Candida albicans
by: Kedric L. Milholland, et al.
Published: (2023-02-01)

Successful management of recalcitrant fungal keratitis with topical caspofungin
by: Goel, Siddhi, et al.
Published: (2022-07-01)

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against <i>Candida</i> Species
by: Zoltán Tóth, et al.
Published: (2020-08-01)

Pathogenesis and Virulence of <i>Candida albicans</i> and <i>Candida glabrata</i>
by: Mariana Henriques, et al.
Published: (2020-09-01)

Development of Echinocandin Resistance in <i>Candida haemulonii</i>: An Emergent, Widespread, and Opportunistic Fungal Pathogen
by: Laura N. Silva, et al.
Published: (2023-08-01)

In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method
by: Qianting Yang, et al.
Published: (2022-09-01)

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four <i>Candida auris</i> Clades in RPMI-1640 in the Absence and Presence of Human Serum
by: Renátó Kovács, et al.
Published: (2021-04-01)

Cellular apoptosis: An alternative mechanism of action for caspofungin against Candida glabrata
by: Parisa Aryamloo, et al.
Published: (2019-06-01)

Oral Cavity and <i>Candida albicans</i>: Colonisation to the Development of Infection
by: Mrudula Patel
Published: (2022-03-01)

Chromosome 1 trisomy confers resistance to aureobasidin A in Candida albicans
by: Lijun Zheng, et al.
Published: (2023-03-01)

The Emergence of Echinocandin-Resistant <i>Candida glabrata</i> Exhibiting High MICs and Related <i>FKS</i> Mutations in Turkey
by: Ali Korhan Sig, et al.
Published: (2021-08-01)

COVID-19-associated candidiasis and the emerging concern of Candida auris infections
by: Chin-Shiang Tsai, et al.
Published: (2023-08-01)

Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic <i>Candida</i> Species
by: Karolina M. Czajka, et al.
Published: (2023-11-01)

Role of <i>Candida albicans</i> in Oral Carcinogenesis
by: Nurina Febriyanti Ayuningtyas, et al.
Published: (2022-12-01)

Filamentation protects Candida albicans from amphotericin B-induced programmed cell death via a mechanism involving the yeast metacaspase, MCA1
by: David J. Laprade, et al.
Published: (2016-04-01)

Zerumbone Disturbs the Extracellular Matrix of Fluconazole-Resistant <i>Candida albicans</i> Biofilms
by: César Augusto Abreu-Pereira, et al.
Published: (2023-05-01)

Synergistic Antifungal Activity of Chitosan with Fluconazole against <i>Candida albicans</i>, <i>Candida tropicalis</i>, and Fluconazole-Resistant Strains
by: Wei-Hsuan Lo, et al.
Published: (2020-11-01)

Echinocandins as Biotechnological Tools for Treating <i>Candida auris</i> Infections
by: Elizabete de Souza Cândido, et al.
Published: (2020-09-01)

Detection of <i>Candida albicans</i> Using a Manufactured Electrochemical Sensor
by: Prakhar Dutta, et al.
Published: (2021-02-01)